Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.985
+0.055 (1.12%)
Apr 22, 2026, 10:35 AM EDT - Market open
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $347.49 million as of April 22, 2026. Its market cap has decreased by -27.12% in one year.
Market Cap
347.49M
Enterprise Value
-267.60M
1-Year Change
-27.12%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $347.49M, an increase of 63.63%. That is a compound annual growth rate of 7.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 343.66M | -30.03% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 383.76M |
| Nautilus Biotechnology | 383.49M |
| Cabaletta Bio | 382.95M |
| YD Bio | 382.54M |
| Puma Biotechnology | 380.05M |
| Monopar Therapeutics | 376.23M |
| DiaMedica Therapeutics | 369.10M |
| Prelude Therapeutics | 366.45M |